Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05916521 · ClinicalTrials.gov registry record · NA
A Three Month Bleeding-Model Clinical Study
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT05916521 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 90 participants.
The verdict
NCT05916521, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The objective of the study is to evaluate the gingivitis control benefit of an established stannous fluoride containing toothpaste relative to a negative control dentifrice.
Interventions
- DRUG 0.454% stannous fluoride
- DRUG 0.76% sodium monofluorophosphate
- DRUG 0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2022-02-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05916521
The ClinicalTrials.gov registry entry for NCT05916521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 0.454% stannous fluoride is the first listed.
NCT05916521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05916521 about?
NCT05916521 is a clinical study titled "A Three Month Bleeding-Model Clinical Study". The objective of the study is to evaluate the gingivitis control benefit of an established stannous fluoride containing toothpaste relative to a negative control dentifrice.
What is the current status of trial NCT05916521?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2021-11-15. Estimated completion is 2022-02-11.
What interventions are being tested in trial NCT05916521?
The interventions under investigation include: 0.454% stannous fluoride (DRUG), 0.76% sodium monofluorophosphate (DRUG), 0.454% stannous fluoride AM and 0.76% sodium monofluorophosphate PM (DRUG).
Who is sponsoring clinical trial NCT05916521?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.